HIV and hepatitis C virus coinfection update Arthur Y. KimRaymond T. Chung OriginalPaper Pages: 83 - 90
Natural history of chronic hepatitis B Alfredo AlbertiGiovanna Fattovich OriginalPaper Pages: 54 - 60
Epidemiology of hepatitis B in adults in the west José M. Sánchez-Tapias OriginalPaper Pages: 49 - 53
Mechanisms of drug resistance to current and future antiviral therapies for hepatitis C virus infection Jean-Michel Pawlotsky OriginalPaper Pages: 38 - 43
Recent peginterferon and ribavirin combination trials Stephanos J. HadziyannisGeorge V. Papatheodoridis OriginalPaper Pages: 30 - 37
Current status of immunomodulatory therapies in HCV infection Paul J. Pockros OriginalPaper Pages: 16 - 22
Adherence to antiviral therapy in chronic hepatitis C Keyur PatelAnouk T. Dev OriginalPaper Pages: 10 - 15
Update on viral kinetics and hcv antiviral therapy Eva HerrmannStefan Zeuzem OriginalPaper Pages: 5 - 9
Hepatitis C in the setting of kidney, heart, lung, and bone marrow transplants Scott KeeleyJohn R. Lake OriginalPaper Pages: 159 - 165
Immunity and persistence in hepatitis C virus infection Anne M. WertheimerHugo R. Rosen OriginalPaper Pages: 152 - 158
Can we identify liver fibrosis in HCV-infected patients without a liver biopsy? Xavier FornsRamón Bataller OriginalPaper Pages: 145 - 151
Steatosis in hepatitis C: What does it mean? Tarik AsselahNathalie BoyerPatrick Marcellin OriginalPaper Pages: 137 - 144
Alcohol and hepatitis C: Implications for disease progression and treatment Alexander Monto OriginalPaper Pages: 125 - 131
Hepatitis C antiviral treatment in special populations Helen S. YeeTeresa L. Wright OriginalPaper Pages: 101 - 107
Hepatitis C in patients with psychiatric disease and substance abuse: Screening strategies and comanagement models of care Jennifer M. LoftisPeter Hauser OriginalPaper Pages: 93 - 100
Treatment of hepatitis B and C following nonliver organ transplants John T. H. T. YuGeorge K. K. Lau OriginalPaper Pages: 82 - 87
Epidemiology and immunopathogenesis of chronic hepatitis B virus infection Edward Doo OriginalPaper Pages: 79 - 81
Treatment of hepatitis B and C following liver transplantation Craig A. SponsellerSanjay Ramrakhiani OriginalPaper Pages: 71 - 78
Hepatitis B: Treatment strategies for currently available drugs Robert P. Perrillo OriginalPaper Pages: 63 - 70
Treatment of chronic hepatitis C: Improved combination therapy Gary L. Davis OriginalPaper Pages: 40 - 46
Treatment of chronic hepatitis C in patients who have failed to respond to IFN or IFN and ribavirin combination therapy Mazen AlsatiePaul Y. Kwo OriginalPaper Pages: 32 - 39
Pegylated interferons in combination with ribavirin for the treatment of chronic hepatitis C Markus CornbergHeiner WedemeyerMichael P. Manns OriginalPaper Pages: 24 - 31
Pegylated interferons: What role will they play in the treatment of chronic hepatitis C? Mitchell L. Shiffman OriginalPaper Pages: 17 - 23
Patients with chronic hepatitis C who have normal ALT: A role for interferon-based therapy? Mark W. RussoRobert S. Brown Jr OriginalPaper Pages: 11 - 16
Steatosis, steatohepatitis: Review of effects on chronic hepatitis C Elizabeth M. BruntDina G. Tiniakos OriginalPaper Pages: 38 - 44
HIV and hepatitis virus infection Winston LeeMichael A. PolesDouglas T. Dieterich OriginalPaper Pages: 30 - 37
Renal involvement in patients with chronic hepatitis C virus infection Marie PhilipneriBahar Bastani OriginalPaper Pages: 23 - 29
Challenges in the HIV patient coinfected with hepatitis C Jonathan Moorman OriginalPaper Pages: 9 - 15
Hepatitis C and Lymphoma Federico SilvestriAlessandra SperottoRenato Fanin OriginalPaper Pages: 5 - 8